EndoSure, Inc.
New Form D on file · 2025-02-20 · the record
Before you sell to, join or invest in EndoSure, Inc.
MentionFox check on EndoSure, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/endosure-inc-form-d-25000001
Check EndoSure, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about EndoSure, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
EndoSure, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-20.
EndoSure, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 20, 2025. The filing reports $150K sold. Its industry group is Other Technology. It names Carlos Babini (President), Mark Noar (Secretary) (SEC Form D, February 20, 2025).
Sell to companies like EndoSure, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
137 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Linework USA INC. | $1.2B | AI and software |
| Linework USA INC. | $326M | AI and software |
| Pathos AI, Inc. | $238M | Biotech |
| Galvanize Therapeutics, Inc. | $136M | Biotech |
| Tractian Inc. | $106M | AI and software |
Is this your company?
New Form D on file · 2025-02-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns EndoSure, Inc.
Free to see. No signup.
Get an email when EndoSure, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when EndoSure, Inc. raises, hires or launches. No email unless you switch it on.
Watch EndoSure, Inc. →Get the full cited report on EndoSure, Inc.
What the filing shows about EndoSure, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on EndoSure, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look EndoSure, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on EndoSure, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives EndoSure, Inc.'s address as 954 Ridgebrook Road Suite 220, Sparks Glencoe, MD 21152.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for EndoSure, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
EndoSure, Inc. is a registered filer with the SEC (CIK 2042877) and has filed since 2025-02-20. 1 filing is on record, the latest on 2025-02-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
EndoSure, Inc.'s Form D of 2025-02-20 names Carlos Babini and Mark Noar as its officers, directors or promoters.
Its new offerings report $150K sold across 1 offering, as its own filings state.
Trailing twelve months. 3852 filings in Other Technology, totalled by week.
On the filing as: Executive Officer, Director.
Carlos Babini is named as President on the Form D that EndoSure, Inc. filed with the SEC on 20 February 2025, one of 2 people that filing names.
On the filing as: Executive Officer, Director.
Mark Noar is named as Secretary on the Form D that EndoSure, Inc. filed with the SEC on 20 February 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-02-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about EndoSure, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on EndoSure, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on EndoSure, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist EndoSure, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for EndoSure, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/endosure-inc-form-d-25000001